Xanthine oxidase inhibitor and therapeutic treatment using same
US4305942A · kind A · utility
4Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1980 |
| Grant date | Dec 15, 1981 |
| Priority date | — |
| Expiry date | Oct 28, 2000 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Therapeutic xanthine oxidase inhibitor composition containing as an active ingredient 3-dimethylamino-7-methyl-1,2-(n-propylmalonyl)-1,2-dihydro-1,2,4-benzotria zine dihydrate of the formula ##STR1## Uratic diathesis in warm-blooded animals is therapeutically treated by administering the aforementioned xanthine oxidase inhibitor to such animals, e.g., human, either orally or by means of an injection, thereby inhibiting their xanthine oxidase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.